title: Complement activation during prolonged extracorporeal membrane oxygenation.
abstract: Short-term cardiopulmonary bypass activates the complement system, possibly resulting in pulmonary dysfunction from granulocyte aggregation and pulmonary endothelial damage. These effects may be inhibited by steroids. Prolonged extracorporeal membrane oxygenation (ECMO) is used for newborn respiratory failure, but the effects of ECMO on complement activation are unknown. Twenty-one newborn infants with respiratory failure treated with ECMO were randomly assigned to group I (control, no steroids) or group II (30 mg/kg intravenous methylprednisolone before ECMO). Depletion assays of C3 and C5 were performed in each group at intervals before and during ECMO (declining values indicate complement activation). The groups were compared for complement levels, survival, time on ECMO and on the ventilator, and total hospitalization time. Steroids significantly shortened the time on ECMO and time on the ventilator after ECMO but did not affect survival or total hospitalization time. Steroids also enhanced activation of C3 and C5. Complement activation occurs during ECMO. Steroid administration paradoxically causes earlier complement activation but shortens ECMO and ventilator times. Complement activation during ECMO is of questionable significance. The benefits of steroids during ECMO may be mediated through other mechanisms.
authors.affiliation: Department of Surgery, St. Louis University School of Medicine, Mo.
authors.forename: S H
authors.initials: SH
authors.lastname: Westfall
authors.forename: C
authors.initials: C
authors.lastname: Stephens
authors.forename: K
authors.initials: K
authors.lastname: Kesler
authors.forename: R H
authors.initials: RH
authors.lastname: Connors
authors.forename: T F
authors.initials: TF
authors.lastname: Tracy
authors.forename: T R
authors.initials: TR
authors.lastname: Weber
mesh_terms: D001724:Birth Weight; D003167:Complement Activation; D003176:Complement C3 / Q000032:analysis; D003182:Complement C5 / Q000032:analysis; D015199:Extracorporeal Membrane Oxygenation; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D007262:Infusions, Intravenous; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D012127:Respiratory Distress Syndrome, Newborn / Q000097:blood / Q000628:therapy*
chemical_list: D003176:Complement C3; D003182:Complement C5; D008775:Methylprednisolone